the modern system of advertising proves the wide prevalence of that form of mental degradation called gullibility. ~ joseph conrad
Bristol-Myers Squibb: Abilify Convention Booth, 2007

BMS won a marketing and merchandising award for this lovely presentation.

Between 2004 and 2006 the FDA MedWatch program received 3,979 Individual Safety Reports naming Abilify (aripiprazole)
the Primary Suspect Drug for 1,182 distinct adverse reactions ranging from ageusia (loss of the sense of taste) to xanthopsia
(visual defect in which everything appears yellow).

Back to Marvelous Mental Medicine A-typical Scam

© 2009 Bonkers Institute for Nearly Genuine Research